These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26005128)

  • 21. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
    Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
    Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
    Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
    Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function.
    Kesby JP; Najera JA; Romoli B; Fang Y; Basova L; Birmingham A; Marcondes MCG; Dulcis D; Semenova S
    Brain Behav Immun; 2017 Oct; 65():210-221. PubMed ID: 28495611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Tat protein exposure potentiates ethanol reward and reinstates extinguished ethanol-conditioned place preference.
    McLaughlin JP; Ganno ML; Eans SO; Mizrachi E; Paris JJ
    Curr HIV Res; 2014; 12(6):415-23. PubMed ID: 25760047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation.
    Singh VB; Wooten AK; Jackson JW; Maggirwar SB; Kiebala M
    J Neurovirol; 2015 Apr; 21(2):186-98. PubMed ID: 25636783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.
    Fan Y; Gao X; Chen J; Liu Y; He JJ
    J Neurosci; 2016 Nov; 36(44):11362-11373. PubMed ID: 27807176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein.
    Zou W; Kim BO; Zhou BY; Liu Y; Messing A; He JJ
    Am J Pathol; 2007 Dec; 171(6):1923-35. PubMed ID: 18055541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
    Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
    Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The frequency of spontaneous seizures in rats correlates with alterations in sensorimotor gating, spatial working memory, and parvalbumin expression throughout limbic regions.
    Wolf DC; Bueno-Júnior LS; Lopes-Aguiar C; Do Val Da Silva RA; Kandratavicius L; Leite JP
    Neuroscience; 2016 Jan; 312():86-98. PubMed ID: 26582750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Region-specific effects of HIV-1 Tat on intrinsic electrophysiological properties of pyramidal neurons in mouse prefrontal cortex and hippocampus.
    Cirino TJ; Harden SW; McLaughlin JP; Frazier CJ
    J Neurophysiol; 2020 Apr; 123(4):1332-1341. PubMed ID: 32101482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration.
    Yang L; Niu F; Yao H; Liao K; Chen X; Kook Y; Ma R; Hu G; Buch S
    J Neuroimmune Pharmacol; 2018 Sep; 13(3):330-344. PubMed ID: 29497921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
    Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
    J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine.
    Walter TJ; Young JW; Milienne-Petiot M; Deben DS; Heaton RK; Letendre S; Grelotti DJ; Perry W; Grant I; Minassian A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110089. PubMed ID: 32891668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis.
    Periyasamy P; Thangaraj A; Guo ML; Hu G; Callen S; Buch S
    J Neurosci; 2018 Jun; 38(23):5367-5383. PubMed ID: 29760177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
    Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
    J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice.
    Kesby JP; Fields JA; Chang A; Coban H; Achim CL; Semenova S;
    Behav Brain Res; 2018 Sep; 349():73-79. PubMed ID: 29709610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.
    Norden DM; Trojanowski PJ; Villanueva E; Navarro E; Godbout JP
    Glia; 2016 Feb; 64(2):300-16. PubMed ID: 26470014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.
    Zucchini S; Pittaluga A; Brocca-Cofano E; Summa M; Fabris M; De Michele R; Bonaccorsi A; Busatto G; Barbanti-Brodano G; Altavilla G; Verlengia G; Cifelli P; Corallini A; Caputo A; Simonato M
    Neurobiol Dis; 2013 Jul; 55():110-9. PubMed ID: 23454193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.
    Salahuddin MF; Qrareya AN; Mahdi F; Jackson D; Foster M; Vujanovic T; Box JG; Paris JJ
    Horm Behav; 2020 Mar; 119():104649. PubMed ID: 31821792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.
    Fitting S; Stevens DL; Khan FA; Scoggins KL; Enga RM; Beardsley PM; Knapp PE; Dewey WL; Hauser KF
    J Pharmacol Exp Ther; 2016 Jan; 356(1):96-105. PubMed ID: 26542403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.